surmount tirzepatide trials SURMOUNT-4 results just published in @JAMA_current ๐Stopping #tirzepatide leads to regain of the majority of the lost weight. Is this a surprising result โ๏ธ No #Obesity is a chronic disease and requires Tirzepatide - A New Dawn
Description
Transitioning from pens to vials If you previously used Mounjaro or Zepbound pre-filled pens and are switching to compounded vials, you need to translate your pen dose into units for your specific vial concentration

This is not a safety concern specific to tirzepatide

No, compounded tirzepatide is not covered by insurance because this medication is custom-made according to the patients need by compounding pharmacies and is not approved by the FDA
(100u) Tirzepatide GLP-1/GIP
95% CI, 12.7-16.7

Growth hormone levels (IGF-1) and inflammatory markers may also inform response
